Application of the patient-reported outcome-based postoperative symptom management model in lung cancer: a multicenter randomized controlled trial protocol.
Journal Information
Full Title: Trials
Abbreviation: Trials
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Ethics approval and consent to participateThis study was approved by the Ethics Committee of Tangdu Hospital on 25 August 2021 (NO. K202108-25). The study was approved by the Ethics Committee of four trial-hosting hospitals on 20 August 2021 (No. K202108-25, X2Y202210, KY2002-0003, SZFYIEC-PJ-2022[78]). This manuscript is based on V.1.2, 20 August 2021, of the protocol. Research staff will obtain informed consent from every participant prior to the study. On the consent form, participants will be asked if they agree to use their data and if they choose to withdraw from the trial. Participants will also be asked to permit the research team to share relevant data with people from other academic institutes who take part in the research or persons from relevant regulatory authorities. This trial does not involve collecting biological specimens for storage. There is no anticipated harm and compensation for trial participation. Post-trial free consultation will be provided for participants at least 12 months. Consent for publicationInformation of participants in this study is strictly confidential. Any information that is published will not reveal the identity of the subjects. The study results will be disseminated in peer-reviewed journal publications and academic conference presentations. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."
"Funding This study is an investigator-initiated trial sponsored by ZG and YL. The sponsor has a role in the study’s design, interpretation of the data, and manuscript writing. This work was supported by the Project assignment of Tangdu Hospital discipline innovation development plan (grant number: 2021LCYJ038) and the Natural Science Foundation of China project (82204151)."
"Trials registration Trials registration number: ChiCTR 2200058876, Registered 18 April 2022"
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025